Qing Tong

785 total citations
32 papers, 573 citations indexed

About

Qing Tong is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Qing Tong has authored 32 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in Qing Tong's work include Immune Cell Function and Interaction (8 papers), Epigenetics and DNA Methylation (5 papers) and Immunotherapy and Immune Responses (5 papers). Qing Tong is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Epigenetics and DNA Methylation (5 papers) and Immunotherapy and Immune Responses (5 papers). Qing Tong collaborates with scholars based in China, United States and Japan. Qing Tong's co-authors include Shan He, Yajun Guo, Yongnian Liu, Yi Zhang, Kazuhiro Mochizuki, Izumi Mochizuki, Yi Zhang, Bohua Li, Shin Mineishi and Lei Zhao and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Qing Tong

30 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qing Tong China 13 304 199 120 110 94 32 573
Ali Rashidfarrokhi United States 8 297 1.0× 205 1.0× 127 1.1× 69 0.6× 46 0.5× 10 583
John B. Beard United States 7 302 1.0× 168 0.8× 63 0.5× 110 1.0× 121 1.3× 8 513
Osnat Bohana‐Kashtan United States 11 232 0.8× 286 1.4× 60 0.5× 90 0.8× 62 0.7× 21 597
Felipe Vences‐Catalán United States 12 228 0.8× 235 1.2× 55 0.5× 110 1.0× 46 0.5× 17 505
Changchuin Mao United States 11 217 0.7× 303 1.5× 49 0.4× 165 1.5× 45 0.5× 20 573
Cosette Rebouissou France 15 300 1.0× 190 1.0× 55 0.5× 187 1.7× 42 0.4× 21 581
Éric Audemard Canada 7 483 1.6× 265 1.3× 209 1.7× 188 1.7× 58 0.6× 9 664
Hyewon Phee United States 17 439 1.4× 451 2.3× 41 0.3× 149 1.4× 99 1.1× 32 866
S. M. Shahjahan Miah United States 18 267 0.9× 393 2.0× 61 0.5× 128 1.2× 78 0.8× 23 665
Michael Nawrath Switzerland 15 291 1.0× 199 1.0× 60 0.5× 125 1.1× 38 0.4× 23 544

Countries citing papers authored by Qing Tong

Since Specialization
Citations

This map shows the geographic impact of Qing Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing Tong more than expected).

Fields of papers citing papers by Qing Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing Tong. The network helps show where Qing Tong may publish in the future.

Co-authorship network of co-authors of Qing Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Qing Tong. A scholar is included among the top collaborators of Qing Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing Tong. Qing Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhongxiao, Bin Zhang, Jia Jia Chan, et al.. (2024). An isoform-resolution transcriptomic atlas of colorectal cancer from long-read single-cell sequencing. Cell Genomics. 4(9). 100641–100641. 7 indexed citations
2.
Yang, Huan, et al.. (2024). CMTM6 promotes hepatocellular carcinoma invasion and metastasis and tumor-associated neutrophil immunoinfiltration through the Wnt/β-catenin pathway. European journal of medical research. 29(1). 595–595. 1 indexed citations
3.
Tong, Qing, et al.. (2023). Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model. Journal of Cancer Research and Clinical Oncology. 149(12). 10685–10700. 6 indexed citations
4.
Tong, Qing, et al.. (2023). NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K/AKT signaling. Scientific Reports. 13(1). 11795–11795.
5.
Tong, Qing, et al.. (2023). SLC12A5 promotes hepatocellular carcinoma growth and ferroptosis resistance by inducing ER stress and cystine transport changes. Cancer Medicine. 12(7). 8526–8541. 16 indexed citations
6.
Zhang, Tao, Yun Dai, Ruyuan Li, et al.. (2023). Efficacy of immune checkpoint inhibitor monotherapy or combined with other small molecule-targeted agents in ovarian cancer. Expert Reviews in Molecular Medicine. 25. e6–e6. 6 indexed citations
7.
Tong, Qing, et al.. (2023). Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy. Materials Today Bio. 23. 100845–100845. 33 indexed citations
8.
Liu, Qiang, Zhenyu Cao, Ju Zhang, et al.. (2022). TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling. Cell & Bioscience. 12(1). 58–58. 10 indexed citations
9.
Fu, Jie, Sixue Wang, Zhenghao Li, et al.. (2022). Comprehensive multiomics analysis of cuproptosis-related gene characteristics in hepatocellular carcinoma. Frontiers in Genetics. 13. 942387–942387. 12 indexed citations
10.
Tong, Qing, Lin Xu, Wukui Huang, et al.. (2022). TRIM36 inhibits tumorigenesis through the Wnt/β-catenin pathway and promotes caspase-dependent apoptosis in hepatocellular carcinoma. Cancer Cell International. 22(1). 278–278. 12 indexed citations
11.
Tong, Qing, Hossein Tabatabaeian, Avencia Sánchez-Mejías, et al.. (2021). MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers. Oncogene. 41(8). 1178–1189. 11 indexed citations
12.
Dai, Yun, Wei‐Ming Xie, Qing Tong, et al.. (2021). PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review. Cancer Investigation. 40(3). 293–309. 1 indexed citations
13.
Fu, Jie, Qiang Liu, Zhenyu Cao, et al.. (2021). Inhibition of the transient receptor potential vanilloid 3 channel attenuates carbon tetrachloride-induced hepatic fibrosis. Biochemical and Biophysical Research Communications. 558. 86–93. 9 indexed citations
14.
Tai, Qinwen, Lin Xu, Yi Hao, et al.. (2021). Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma. Cancer Gene Therapy. 28(6). 719–736. 52 indexed citations
15.
Toms, Derek, et al.. (2020). Automated Hypothesis Generation to Identify Signals Relevant in the Development of Mammalian Cell and Tissue Bioprocesses, With Validation in a Retinal Culture System. Frontiers in Bioengineering and Biotechnology. 8. 534–534. 1 indexed citations
16.
Chen, Xin, et al.. (2015). Anemia and Inflammation in ST-Segment Elevation Myocardial Infarction. The American Journal of the Medical Sciences. 349(6). 493–498. 11 indexed citations
17.
Li, Bohua, Yanchun Meng, Lei Zheng, et al.. (2013). Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization. Cancer Research. 73(21). 6471–6483. 47 indexed citations
18.
19.
Qian, Weizhu, Bohua Li, Dapeng Zhang, et al.. (2010). Development and characterization of a novel anti-IgE monoclonal antibody. Biochemical and Biophysical Research Communications. 395(4). 547–552. 5 indexed citations
20.
Li, Bohua, Lei Zhao, Huaizu Guo, et al.. (2009). Characterization of a rituximab variant with potent antitumor activity against rituximab-resistant B-cell lymphoma. Blood. 114(24). 5007–5015. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ali Rashidfarrokhi Breakdown of academic impact, for papers by John B. Beard Breakdown of academic impact, for papers by Osnat Bohana‐Kashtan Breakdown of academic impact, for papers by Felipe Vences‐Catalán Breakdown of academic impact, for papers by Changchuin Mao Breakdown of academic impact, for papers by Cosette Rebouissou Breakdown of academic impact, for papers by Éric Audemard Breakdown of academic impact, for papers by Hyewon Phee Breakdown of academic impact, for papers by S. M. Shahjahan Miah Breakdown of academic impact, for papers by Michael Nawrath
Rankless by CCL
2026